Hodgkin lymphoma is a haematological malignancy predominantly affecting young adults. Hodgkin lymphoma is a highly curable disease by current treatment standards. Latest treatment guidelines for Hodgkin lymphoma however imply access to diagnostic and treatment modalities that may not be available in settings with restricted healthcare resources. Considerable discrepancies in Hodgkin lymphoma patient survival exist, with poorer outcomes reported in resources-constrained settings. Resources-stratified guidelines for diagnosis, staging and treatment of Hodgkin lymphoma were derived in an effort to optimize patient outcome provided a given setting of available resources. These guidelines were derived based on the framework of the Breast Health ...
Hodgkin lymphoma is a highly curable malignancy in early and advanced stages. Most patients are diag...
This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and ...
International audienceHodgkin lymphoma is a highly curable disease. Although most patients achieve c...
Hodgkin lymphoma is a haematological malignancy predominantly affecting young adults. Hodgkin lympho...
This guideline was compiled according to the British Society for Haematology (BSH) process at BSH Gu...
Purpose: To provide evidence-based recommendations for health care professionals on diagnosis and ma...
With continued progress and success in clinical care, the management of patients with Hodgkin lympho...
The Hodgkin's Lymphoma Committee of the Lymphoma Study Association (LYSA) gathered in 2012 to prepar...
Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...
This paper examines the evidence available to guide treatment decisions in three areas of Hodgkin’s ...
Background: Improvement of lymphoma therapy is largely driven by clinical therapy optimization proto...
Hodgkin lymphoma (HL) is a rare malignancy accounting for roughly 15% of all lymphomas and mostly af...
Hodgkin lymphoma (HL) is a rare cancer of the lymphoid system. It clinically presents with swollen l...
Hodgkin lymphoma is the most frequent hematologic neoplasia in young adults. Most patients (> 80 %) ...
The management of HD continues to evolve, and the NCCN guidelines have undergone major changes since...
Hodgkin lymphoma is a highly curable malignancy in early and advanced stages. Most patients are diag...
This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and ...
International audienceHodgkin lymphoma is a highly curable disease. Although most patients achieve c...
Hodgkin lymphoma is a haematological malignancy predominantly affecting young adults. Hodgkin lympho...
This guideline was compiled according to the British Society for Haematology (BSH) process at BSH Gu...
Purpose: To provide evidence-based recommendations for health care professionals on diagnosis and ma...
With continued progress and success in clinical care, the management of patients with Hodgkin lympho...
The Hodgkin's Lymphoma Committee of the Lymphoma Study Association (LYSA) gathered in 2012 to prepar...
Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...
This paper examines the evidence available to guide treatment decisions in three areas of Hodgkin’s ...
Background: Improvement of lymphoma therapy is largely driven by clinical therapy optimization proto...
Hodgkin lymphoma (HL) is a rare malignancy accounting for roughly 15% of all lymphomas and mostly af...
Hodgkin lymphoma (HL) is a rare cancer of the lymphoid system. It clinically presents with swollen l...
Hodgkin lymphoma is the most frequent hematologic neoplasia in young adults. Most patients (> 80 %) ...
The management of HD continues to evolve, and the NCCN guidelines have undergone major changes since...
Hodgkin lymphoma is a highly curable malignancy in early and advanced stages. Most patients are diag...
This topic addresses the treatment of newly diagnosed patients with favorable prognosis stage I and ...
International audienceHodgkin lymphoma is a highly curable disease. Although most patients achieve c...